Pfizer Will No Longer Fund CME Through Med Ed Firms

Medical Marketing and Media magazine reports that Pfizer will no longer fund CME through medical education and communications companies.

This announcement comes days after the same magazine wrote about a letter Senator Herb Kohl (D-WI) wrote to ACCME chief Murray Kopelow about a CME event that recommended testing all pregnant women for herpes. Senator Kohl contends there is no medical evidence that supports this recommendation, which calls into question the motives of the event grantor, GSK, which is the maker of Valtrex (a herpes drug).

Since Pfizer alone spent $314 million on CME in 2005 - some of that on web-base streaming media - it is clear that this vertical will be undergoing significant change.